Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study.

Maria Di PietrantonioLucia BresciniJennifer CandiGianluca MorroniFrancesco PallottaSara MazzantiPaolo MantiniBianca CandelaresiSilvia OlivieriFrancesco GinevriGiulia CesarettiSefora CastellettiEmanuele CocciRosaria G PoloElisabetta CeruttiOriana SimonettiOscar CirioniMarcello TavioAndrea GiacomettiFrancesco Barchiesi

Published in: Antibiotics (Basel, Switzerland) (2022)

Ceftazidime-avibactam showed high efficacy in infections caused by MDR Gram-negative pathogens with limited therapeutic options.

Keyphrases

gram negative
multidrug resistant
drug resistant
acinetobacter baumannii
klebsiella pneumoniae
combination therapy
pseudomonas aeruginosa
replacement therapy